Blog

Delighted to introduce our Scientific Advisory Board – Sable Bio

Photo from Sable Bio/LinkedIn

May 20, 2024, 03:50

Delighted to introduce our Scientific Advisory Board – Sable Bio

Sable Bio posted on LinkedIn:

“We are delighted to introduce our Scientific Advisory Board, who are helping us shape our innovative solutions for understanding target driven safety.

With experience spanning academia, pharma and biotech, we are in excellent hands!

Find out more here.

Paul Brennan
– Professor University of Oxford, Director Centre for Medicine Discovery
Anne Phelan
– CSO, BenevolentAI
Bryn Williams-Jones
– Founder and COO, Connected Discovery Ltd
Justin Stebbing
– Editor-in-Chief Oncogene, Professor of Biomedical Sciences, ARU, Cambridge, previously UK’s first NIHR Research Translational Professor”

Source: Sable Bio/LinkedIn

Anne Phelan BenevolentAI Bryn Williams-Jones cancer Connected Discovery Ltd Director Centre for Medicine Discovery Justin Stebbing NIHR Research Translational Professor OncoDaily oncogene Oncology Paul Brennan Sable Bio University of Oxford

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage